peter c. black, md, facs, frcsc, on the usefulness of molecular markers in bladder cancer treatment
Published 6 years ago • 18 plays • Length 1:45Download video MP4
Download video MP3
Similar videos
-
1:21
peter c. black, md, facs, frcsc, on molecular characterization & bladder subtyping data
-
1:15
peter c. black, md, facs, frcsc, on impact of the cancer genome atlas project in bladder cancer
-
0:46
peter c. black, md, facs, frcsc, regarding checkpoint blockade in non-muscle invasive bladder cancer
-
19:51
vancouver patient meeting: dr. peter black, md, frcsc
-
8:26
the role of molecular markers in bladder cancer
-
6:01
what urologist don't tell their bladder cancer patients
-
14:48
urinary markers in nmibc what's new youtube
-
3:23
what is a cystoscopy: evaluation of your bladder
-
0:46
molecular markers guiding treatment approaches in bladder cancer
-
15:42
urinary markers in bladder cancer
-
1:09
peter c. black, md, facs, frcsc, considers preferred checkpoint inhibitors for urothelial carcinoma
-
1:26
analyzing the role of molecular profiling in patients with bladder cancer
-
1:14
dr. peter black on bladder cancer research
-
42:10
presentation: new innovations in the treatment of bladder cancer - by dr. peter black
-
1:48
dr. bochner on molecular profiling in bladder cancer
-
1:23
dr. black on biomarkers for immunotherapy in bladder cancer
-
43:48
urinary molecular marker tests in bladder cancer: an overview of cxbladder
-
20:31
webinar - epigenetic marker for the monitoring of bladder tumours
-
0:57
dr. black on sequencing of immunotherapy in bladder cancer
-
1:29
dr. bochner on the standardization of molecular profiling in bladder cancer
-
1:17
what is the most common type of bladder cancer and how is it detected?
-
1:00
dr. black on combinations with durvalumab in bladder cancer